AAAAAA
Results:
1-12
|
Results: 12
Authors:
LANGNER A
STAPOR W
AMBROZIAK M
Citation: A. Langner et al., VITAMIN-D-3 METABOLITES AND ANALOGS IN THE TREATMENT OF SCALP PSORIASIS, Journal of dermatological treatment, 9, 1998, pp. 41-45
Authors:
MUHLENFELD K
LANGNER A
Citation: K. Muhlenfeld et A. Langner, BIOTRANSFORMATION AND TOXICITY OF THE LIPOXYGENASE INHIBITOR 2-HYDROXY-5-METHYLLAUROPHENONE OXIME (FLM-5011) ON HEP G2 CELLS, Archiv der pharmazie, 331(7-8), 1998, pp. 259-261
Authors:
LANGNER A
NICHOLS C
CHENG K
TOYODA Y
THOMSON L
GARNETT KM
DOREY CK
Citation: A. Langner et al., EFFECT OF SUPPLEMENTAL BETA-CAROTENE ON LIGHT DAMAGE TO RETINA, Investigative ophthalmology & visual science, 38(4), 1997, pp. 1417-1417
CALCITRIOL OINTMENT IN THE TREATMENT OF FACIAL, HAIRLINE AND RETROAURICULAR CHRONIC PLAQUE PSORIASIS
Authors:
LANGNER A
STAPOR V
VERJANS H
ELZERMAN J
Citation: A. Langner et al., CALCITRIOL OINTMENT IN THE TREATMENT OF FACIAL, HAIRLINE AND RETROAURICULAR CHRONIC PLAQUE PSORIASIS, Journal of dermatological treatment, 7, 1996, pp. 15-18
Authors:
LANGNER A
RENTSCH C
NERLICH C
RITTNER I
KUHN H
SCHEWE T
FRANKE P
Citation: A. Langner et al., INVESTIGATIONS ON THE BIOTRANSFORMATION O F THE LIPOXYGENASE INHIBITOR 2-HYDROXY-5-METHYL-LAUROPHENONE-OXIME (FLM-5011), Die Pharmazie, 51(6), 1996, pp. 403-409
Authors:
LANGNER A
ASHTON P
VANDEKERKHOF PCM
VERJANS H
Citation: A. Langner et al., A LONG-TERM MULTICENTER ASSESSMENT OF THE SAFETY AND TOLERABILITY OF CALCITRIOL OINTMENT IN THE TREATMENT OF CHRONIC PLAQUE PSORIASIS, British journal of dermatology, 135(3), 1996, pp. 385-389
COMBINED TREATMENT OF CHRONIC PLAQUE PSORIASIS WITH ETRETINATE AND TOPICAL 1,25-DIHYDROXYVITAMIN D-3
Authors:
LANGNER A
STAPOR V
WOLSKA H
VERJANS H
ELZERMAN JR
Citation: A. Langner et al., COMBINED TREATMENT OF CHRONIC PLAQUE PSORIASIS WITH ETRETINATE AND TOPICAL 1,25-DIHYDROXYVITAMIN D-3, Journal of dermatological treatment, 6(1), 1995, pp. 53-53
Authors:
LANGNER A
MELZIG MF
KEMPA S
KRAUSE A
Citation: A. Langner et al., THE USE OF LYMPHOCYTE-CULTURES FOR THE IN VESTIGATION ON THE BIOTRANSFORMATION OF DRUGS, Die Pharmazie, 50(2), 1995, pp. 130-138
Authors:
LANGNER A
KEMPA S
NERLICH C
FRANKE P
PFEIFER S
Citation: A. Langner et al., INVESTIGATIONS ON THE BIOTRANSFORMATION O F THE IMMUNOSTIMULATOR 3-(2-MERCAPTOETHYL)QUINAZOLINE-2,4(1H,3H)-DIONE (AWD-100-041), Die Pharmazie, 49(2-3), 1994, pp. 169-175
Authors:
ROHDE D
STAMPOR V
LANGNER A
CHRISTOPHERS E
Citation: D. Rohde et al., CUTANEOUS INFLAMMATION MEDIATED BY INTRADERMAL INJECTION OF RANTES AND FMLP - ULTRASTRUCTURAL AND IMMUNOHISTOLOGICAL FEATURES, Journal of investigative dermatology, 103(3), 1994, pp. 425-425
Authors:
LANGNER A
RATZER J
RICKERT H
NERLICH C
FRANKE P
Citation: A. Langner et al., INVESTIGATIONS ON THE BIOTRANSFORMATION O F THE ANTICONVULSANT 4-P-CHLOROPHENYLPYRROLE-3-MORPHOLINO-2-CARBOXYLIC ACID METHYL-ESTER (AWD-140-076), Die Pharmazie, 48(11), 1993, pp. 849-853
Authors:
LANGNER A
VERJANS H
STAPOR V
MOL M
FRACZYKOWSKA M
Citation: A. Langner et al., TOPICAL CALCITRIOL IN THE TREATMENT OF CHRONIC PLAQUE PSORIASIS - A DOUBLE-BLIND-STUDY, British journal of dermatology, 128(5), 1993, pp. 566-571
Risultati:
1-12
|